CN109758401A - A kind of frost with powder for dispersing blood stasis tubercle effect - Google Patents
A kind of frost with powder for dispersing blood stasis tubercle effect Download PDFInfo
- Publication number
- CN109758401A CN109758401A CN201910244487.0A CN201910244487A CN109758401A CN 109758401 A CN109758401 A CN 109758401A CN 201910244487 A CN201910244487 A CN 201910244487A CN 109758401 A CN109758401 A CN 109758401A
- Authority
- CN
- China
- Prior art keywords
- frost
- tubercle
- extract
- powder
- blood stasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
A kind of frost with powder for dispersing blood stasis tubercle effect, the raw material including following mass percentage are made: water, ring five dimethyl silicone polymer and cyclohexasiloxane, Butyrospermum parkii fruit rouge, butanediol, stearine and PE-100 stearate, Rhizoma Chuanxiong root extract, ginger oil, Gentrin Knotweed P.E, palm leaf resin composition.The present invention emulsifies Gentrin Knotweed P.E, palm leaf tree extract and the skin conditioning agents such as Rhizoma Chuanxiong extract and ginger oil with antiinflammation, the dissipating bind frost applied to skin care industry is made in conjunction with emollient, play diminishing inflammation and resolving masses, more traditional diminishing inflammation and resolving masses drug, the present invention can be used as skin care item in daily life and be used for a long time, make user's diminishing inflammation and resolving masses with symptoms such as scleroma, siltings, while also effectively preventing the symptoms such as swelling and pain, scleroma for inferior health user.
Description
Technical field
The present invention relates to cosmetic field, especially a kind of frost with powder for dispersing blood stasis tubercle effect.
Background technique
Currently, some illnesss such as rheumatism joint swelling and pain, scapulohumeral periarthritis, synovitis, osteoproliferation, cervical spondylosis, Waist disc is prominent
Out, the side effect of lump in breast, proliferation of mammary gland etc., western medicine is big, is also easy to produce drug resistance, palliative, produces little effect.In
Medicine pain relieving ointment is a kind of to be specifically used to treat the illnesss such as swelling and pain, scleroma or silting, Small side effects by well known.
The Chinese medicine elimination of dispersing swelling and dissipating binds first is that with have the effects that removing toxic substances, promoting blood circulation, dissipating bind, dredging collateral medicament composing prescription,
It dissipates to swell from the beginning of ulcer sores, poison with treatment and disappear, prevent the therapy at purulence, be suitable for body surface carbuncle, malignant boil, sore, erysipelas, streamer, goitre, tumor
And the diseases such as acute appendicitis are from the beginning of clinically should be noted that following two points when specifically used removing swelling and lump:
1, contraindication in pregnancy；
2, large carbuncle illness at the purulence phase or burst after, should not use, dispersing swelling and dissipating binds it is most commonly seen be the proliferation of mammary gland, mammary gland
The diseases such as tubercle, mastadenoma, ovarian cyst, ovarioncus, fibroid, thyroid adenoma, thyroid nodule and subcutaneous fat tumor,
The middle proliferation of mammary gland refers to breast epithelium and proliferation of fibrous tissue, the retrogression pathological changes of breast tissue conduit and newborn leaflet in structure
And the growth of progressive connective tissue, it is the most common breast disease of women, the cause of disease mainly has the following:
1. the spirit excessively bad mental element such as anxiety, mood excessively excitement, may all make the mammary gland that should be restored
Hyperplastic tissue cannot restore or meromorphosis, over time, just forms the proliferation of mammary gland, and these undesirable direct stimulations are also
It can aggravate existing proliferation of mammary gland symptom；
2. more than times the stream of people easily sends out the proliferation of mammary gland；
3. estrogen absolutely or it is opposite increase, breast structure disorder caused by progestational hormone is absolute or relative reduction；
4. taking health care product, contraceptive containing estrogen for a long time, it is also possible to cause the proliferation of mammary gland.
At present treatment dispersing swelling and dissipating binds agent efficacy it is poor, cannot effectively be treated by external application the proliferation of mammary gland, Breast Nodules,
The diseases such as mastadenoma, ovarian cyst, ovarioncus, fibroid, thyroid adenoma, thyroid nodule, subcutaneous fat tumor, at the same it is existing
Traditional-Chinese-medicine-type dissipating bind Medicated Permeation cause therapeutic effect slow slowly, treatment cycle is long, and such product can't become the of user
One selection is badly in need of a kind of combination in everyday skincare on the market and has the creams of dispersing swelling and dissipating binds, can be in daily user's skin care
Reach dispersing swelling and dissipating binds in use, and to illnesss such as some swelling and pain of inferior health user prevention, scleroma or siltings.
Summary of the invention
In order to overcome the disadvantages mentioned above of the prior art, the object of the present invention is to provide a kind of with powder for dispersing blood stasis tubercle effect
Frost.
The technical solution adopted by the present invention to solve the technical problems is: a kind of frost with powder for dispersing blood stasis tubercle effect, uses
In dispersing swelling and dissipating binds, it is made including the raw material of following mass percentage:
60-70% water；
3-6% ring five dimethyl silicone polymer and cyclohexasiloxane；
2-4% Butyrospermum parkii fruit rouge；
2-4% butanediol；
1-2% stearine and PE-100 stearate；
1-2%C12-20 alkyl glucoside and C14-22 alcohol；
1-2% hydroxy-ethyl acrylate/sodium acryloyldimethyl taurate copolymers；
0.5-1.5% caprylic/capric triglyceride；
0.2-1% parahydroxyacet-ophenone；
0.2-1%1,2- ethylene glycol；
4-6% Rhizoma Chuanxiong root extract；
2-4% ginger oil；
4-6% Gentrin Knotweed P.E；
4-6% slaps leaf resin composition；
0.2% allantoin；0.1% methyl hydroxybenzoate；0.2% pepper extract；0.05% Nipasol；0.1% tocopherol
Acetic acid esters；0.02%EDTA disodium.
As a further improvement of the present invention: the dissipating bind frost includes that the raw material of following mass percentage is made:
It is 64.83% water, 4% ring five dimethyl silicone polymer and cyclohexasiloxane, 3% Butyrospermum parkii fruit rouge, 3% butanediol, 1.5% sweet
Oleostearin acid esters and PE-100 stearate, 1.5%C12-20 alkyl glucoside and C14-22 alcohol, 1.5% hydroxy-ethyl acrylate/
Sodium acryloyldimethyl taurate copolymers, 1% caprylic/capric triglyceride, 0.5% parahydroxyacet-ophenone, 0.5%1,2- second
Glycol, 0.2% allantoin, 0.1% methyl hydroxybenzoate, 0.2% pepper extract, 0.05% Nipasol, 0.1% tocopheryl acetate
Ester, 0.02%EDTA disodium, 5% Rhizoma Chuanxiong root extract, 3% ginger oil, 5% Gentrin Knotweed P.E, 5% palm leaf resin composition.
As a further improvement of the present invention: the Rhizoma Chuanxiong root extract is for the extraction of umbelliferae Rhizome of Ligusticum Sinense Oliv. Cv. Chuanxiong
Object has the effect of blood-activating and qi-promoting, wind-expelling pain-stopping.
As a further improvement of the present invention: the ginger oil is the essential oil extracted from ginger, has anti-inflammatory
Effect can help the drop of water raw, it is active releive it is tired.
As a further improvement of the present invention: main component includes resveratrol and rheum officinale in the Gentrin Knotweed P.E
Element, resveratrol facilitate cardiovascular health and promoting blood circulation, mitigate pain, clearing heat and removing internal wetness, and detoxification removes phlegm.Other ingredients include red anthracene
Ketone, Physcion and Rhein all have anti-inflammatory, arthritis of dispelling and antimicrobial acivity.
As a further improvement of the present invention: the palm leaf resin composition is by palm leaf tree extract, water, dipropylene glycol, hydroxyl
Benzene methyl and Nipasol mixing composition.The palm leaf tree extract has excellent anti-oxidant, antibacterial, anti-inflammatory, dispersibility,
Frequently as Derma-Guard etc., it is applied to personal-care supplies field.
As a further improvement of the present invention: including following preparation step:
1) to each raw material Weighing in proportion；
2) water and butanediol are put into the first dissolving tank and are heated to 80 DEG C of dissolutions, by ring five dimethyl silicone polymer, ring
Own siloxanes, Butyrospermum parkii fruit rouge, stearine, PE-100 stearate be put into the second dissolving tank be heated to 80 DEG C it is molten
Solution；
3) raw material of the first dissolving tank and the second dissolving tank is put into emulsion pot and is thoroughly mixed, temperature is kept
At 80 DEG C；
4) C12-20 alkyl glucoside, C14-22 alcohol, acrylic acid hydroxyl is added in heat preservation after emulsification kettle temperature being down to 65 DEG C
Ethyl ester/sodium acryloyldimethyl taurate copolymers, caprylic/capric triglyceride and EDETATE SODIUM, are thoroughly mixed；
5) parahydroxyacet-ophenone, 1,2- ethylene glycol, allantoin, oxybenzene is added in heat preservation after emulsification kettle temperature being down to 45 DEG C
Methyl esters, pepper extract, Nipasol, tocopherol acetate, Rhizoma Chuanxiong root extract, ginger oil, Gentrin Knotweed P.E, are sufficiently stirred
Mixing；
6) 45 DEG C are maintained the temperature in emulsion pot, are continuously added palm leaf resin composition, are thoroughly mixed；By emulsion pot
Interior temperature is down to 35 DEG C, discharging.
Compared with prior art, the beneficial effects of the present invention are:
The present invention is by Gentrin Knotweed P.E, the palm leaf tree extract and skins such as Rhizoma Chuanxiong extract and ginger oil with antiinflammation
Skin conditioner is emulsified, and the dissipating bind frost applied to skin care industry is made in conjunction with emollient, plays diminishing inflammation and resolving masses, more traditional anti-inflammatory
Dissipating bind drug, the present invention can be used as skin care item in daily life and be used for a long time, and make user's anti-inflammatory with symptoms such as scleroma, siltings
Dissipating bind, while also effectively preventing the symptoms such as swelling and pain, scleroma for inferior health user.
Specific embodiment
Now in conjunction with embodiment, the present invention is further described:
A kind of frost with powder for dispersing blood stasis tubercle effect, the raw material including following mass percentage are made: 64.83% water,
4% ring five dimethyl silicone polymer and cyclohexasiloxane, 3% Butyrospermum parkii fruit rouge, 3% butanediol, 1.5% stearine
With PE-100 stearate, 1.5%C12-20 alkyl glucoside and C14-22 alcohol, 1.5% hydroxy-ethyl acrylate/acryloyl diformazan
Base Taurate Copolymer, 1% caprylic/capric triglyceride, 0.5% parahydroxyacet-ophenone, 0.5%1,2- ethylene glycol, 0.2%
Allantoin, 0.1% methyl hydroxybenzoate, 0.2% pepper extract, 0.05% Nipasol, 0.1% tocopherol acetate, 0.02%
EDETATE SODIUM, 5% Rhizoma Chuanxiong root extract, 3% ginger oil, 5% Gentrin Knotweed P.E, 5% palm leaf resin composition, the palm leaf tree group
Object is closed to be made of the mixing of palm leaf tree extract, water, dipropylene glycol, methyl hydroxybenzoate and Nipasol.
A kind of frost with powder for dispersing blood stasis tubercle effect, including following preparation step:
1) to each raw material Weighing in proportion；
2) water and butanediol are put into the first dissolving tank and are heated to 80 DEG C of dissolutions, by ring five dimethyl silicone polymer, ring
Own siloxanes, Butyrospermum parkii fruit rouge, stearine, PE-100 stearate be put into the second dissolving tank be heated to 80 DEG C it is molten
Solution；
3) raw material of the first dissolving tank and the second dissolving tank is put into emulsion pot and is thoroughly mixed, temperature is kept
At 80 DEG C；
4) C12-20 alkyl glucoside, C14-22 alcohol, acrylic acid hydroxyl is added in heat preservation after emulsification kettle temperature being down to 65 DEG C
Ethyl ester/sodium acryloyldimethyl taurate copolymers, caprylic/capric triglyceride and EDETATE SODIUM, are thoroughly mixed；
5) parahydroxyacet-ophenone, 1,2- ethylene glycol, allantoin, oxybenzene is added in heat preservation after emulsification kettle temperature being down to 45 DEG C
Methyl esters, pepper extract, Nipasol, tocopherol acetate, Rhizoma Chuanxiong root extract, ginger oil, Gentrin Knotweed P.E, are sufficiently stirred
Mixing；
6) 45 DEG C are maintained the temperature in emulsion pot, are continuously added palm leaf resin composition, are thoroughly mixed；By emulsion pot
Interior temperature is down to 35 DEG C, discharging.
Claims (4)
1. a kind of frost with powder for dispersing blood stasis tubercle effect, it is characterized in that the raw material including following mass percentage is made:
60-70% water；
3-6% ring five dimethyl silicone polymer and cyclohexasiloxane；
2-4% Butyrospermum parkii fruit rouge；
2-4% butanediol；
1-2% stearine and PE-100 stearate；
1-2%C12-20 alkyl glucoside and C14-22 alcohol；
1-2% hydroxy-ethyl acrylate/sodium acryloyldimethyl taurate copolymers；
0.5-1.5% caprylic/capric triglyceride；
0.2-1% parahydroxyacet-ophenone；
0.2-1%1,2- ethylene glycol；
4-6% Rhizoma Chuanxiong root extract；
2-4% ginger oil；
4-6% Gentrin Knotweed P.E；
4-6% slaps leaf resin composition；
0.2% allantoin；0.1% methyl hydroxybenzoate；0.2% pepper extract；0.05% Nipasol；0.1% tocopheryl acetate
Ester；0.02%EDTA disodium.
2. a kind of frost with powder for dispersing blood stasis tubercle effect according to claim 1, it is characterized in that: being contained by following quality percentage
The raw material of amount is made: 64.83% water, 4% ring five dimethyl silicone polymer and cyclohexasiloxane, 3% Butyrospermum parkii fruit rouge, 3%
Butanediol, 1.5% stearine and PE-100 stearate, 1.5%C12-20 alkyl glucoside and C14-22 alcohol,
1.5% hydroxy-ethyl acrylate/sodium acryloyldimethyl taurate copolymers, 1% caprylic/capric triglyceride, 0.5% pair of hydroxyl
Acetophenone, 0.5%1,2- ethylene glycol, 0.2% allantoin, 0.1% methyl hydroxybenzoate, 0.2% pepper extract, 0.05% oxybenzene third
Ester, 0.1% tocopherol acetate, 0.02%EDTA disodium, 5% Rhizoma Chuanxiong root extract, 3% ginger oil, 5% Gentrin Knotweed P.E,
5% palm leaf resin composition.
3. a kind of frost with powder for dispersing blood stasis tubercle effect according to claim 1 to 2, it is characterized in that: the palm leaf tree combines
Object is made of the mixing of palm leaf tree extract, water, dipropylene glycol, methyl hydroxybenzoate and Nipasol.
4. a kind of frost with powder for dispersing blood stasis tubercle effect according to claim 1 or claim 2, it is characterized in that: including that following preparation walks
It is rapid:
1) to each raw material Weighing in proportion；
2) water and butanediol are put into the first dissolving tank and are heated to 80 DEG C of dissolutions, by ring five dimethyl silicone polymer, hexamethylene silicon
Oxygen alkane, Butyrospermum parkii fruit rouge, stearine, PE-100 stearate, which are put into the second dissolving tank, is heated to 80 DEG C of dissolutions；
3) raw material of the first dissolving tank and the second dissolving tank is put into emulsion pot and is thoroughly mixed, temperature is maintained at 80
℃；
4) will emulsification kettle temperature be down to 65 DEG C after heat preservation be added C12-20 alkyl glucoside, C14-22 alcohol, hydroxy-ethyl acrylate/
Sodium acryloyldimethyl taurate copolymers, caprylic/capric triglyceride and EDETATE SODIUM, are thoroughly mixed；
5) parahydroxyacet-ophenone, 1,2- ethylene glycol, allantoin, oxybenzene first is added in heat preservation after emulsification kettle temperature being down to 45 DEG C
Ester, pepper extract, Nipasol, tocopherol acetate, Rhizoma Chuanxiong root extract, ginger oil, Gentrin Knotweed P.E, are sufficiently stirred mixed
It closes；
6) 45 DEG C are maintained the temperature in emulsion pot, are continuously added palm leaf resin composition, are thoroughly mixed；It will be in emulsion pot
Temperature is down to 35 DEG C, discharging.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910244487.0A CN109758401A (en) | 2019-03-28 | 2019-03-28 | A kind of frost with powder for dispersing blood stasis tubercle effect |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910244487.0A CN109758401A (en) | 2019-03-28 | 2019-03-28 | A kind of frost with powder for dispersing blood stasis tubercle effect |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109758401A true CN109758401A (en) | 2019-05-17 |
Family
ID=66459951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910244487.0A Pending CN109758401A (en) | 2019-03-28 | 2019-03-28 | A kind of frost with powder for dispersing blood stasis tubercle effect |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109758401A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1636582A (en) * | 2002-01-18 | 2005-07-13 | 屈旭 | Medicated bra for treating mastoproliferation |
| CN107157830A (en) * | 2017-05-18 | 2017-09-15 | 秀瑞斯（天津）科技有限公司 | Buttocks compacts formula, preparation method and application method |
| CN107596076A (en) * | 2017-11-07 | 2018-01-19 | 沈阳兴润药物研究所 | A kind of daubing medicament for treating pain |
| CN109260445A (en) * | 2018-11-27 | 2019-01-25 | 李丹丹 | A kind of draft liquid and preparation method thereof |
| CN109512761A (en) * | 2018-12-11 | 2019-03-26 | 广州市白云区天芳化妆品厂 | A kind of quantum light-wave energy proceeds blood cycle frost and preparation method thereof |
-
2019
- 2019-03-28 CN CN201910244487.0A patent/CN109758401A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1636582A (en) * | 2002-01-18 | 2005-07-13 | 屈旭 | Medicated bra for treating mastoproliferation |
| CN107157830A (en) * | 2017-05-18 | 2017-09-15 | 秀瑞斯（天津）科技有限公司 | Buttocks compacts formula, preparation method and application method |
| CN107596076A (en) * | 2017-11-07 | 2018-01-19 | 沈阳兴润药物研究所 | A kind of daubing medicament for treating pain |
| CN109260445A (en) * | 2018-11-27 | 2019-01-25 | 李丹丹 | A kind of draft liquid and preparation method thereof |
| CN109512761A (en) * | 2018-12-11 | 2019-03-26 | 广州市白云区天芳化妆品厂 | A kind of quantum light-wave energy proceeds blood cycle frost and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| 周德生: "《要药分剂释义》", 31 January 2011, 山西科学技术出版社 * |
| 周祯祥等: "《中药学 新世纪第2版》", 30 August 2016, 中国中医药出版社 * |
| 张语庭: "《精油生活秘笈》", 31 May 2017, 华中科技大学出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI290468B (en) | Itch-relief composition and wound-cure promotion composition | |
| CN1966042A (en) | Externally applied ointment for treating hyperosteogeny and preparation method thereof | |
| CN106075399A (en) | For the compositions of corticosteroid dermatitis, preparation and preparation method and application | |
| CN104740321A (en) | Traditional Chinese medicine composition for removing chloasma and preparation method thereof | |
| CN104826016B (en) | A kind of pharmaceutical composition and its preparation method and application for treating the proliferation of mammary gland | |
| CN100398141C (en) | Medicine for treating hyperplasia of mammary glands and preparation method thereof | |
| CN108969440A (en) | A kind of sports frost and preparation method thereof | |
| CN103655315B (en) | Black eye removal eye mask and preparation method thereof | |
| CN102552608B (en) | Medicine composition used for treating fracture and bone injury, preparation method thereof, and purpose thereof | |
| CN104644535A (en) | Hair and body wash powder | |
| CN106963923A (en) | A kind of Chinese medicine composition and preparation method and application with analgesic activity | |
| CN109758401A (en) | A kind of frost with powder for dispersing blood stasis tubercle effect | |
| CN110812377B (en) | Acne treatment and repair composition and application thereof | |
| CN104524422B (en) | A kind of pill that treating gynecomastia and preparation method | |
| CN110464752A (en) | A kind of Chinese medicine composition that dispelling body odour and its ointment and preparation method | |
| KR20200008289A (en) | Herbal medicine composition for prevention and improvement of squama | |
| CN103989968A (en) | Oral traditional Chinese medicinal composition for treating cervical spinal stenosis | |
| CN102949461B (en) | External traditional Chinese medicine composition and preparation for treating nodular type acnes and preparation method thereof | |
| CN1657078A (en) | Medicine for treating mastosis | |
| CN1167431C (en) | Chinese medicine plaster for treating mastoproliferation and its prepn | |
| CN105056132A (en) | Traditional Chinese medicine composition for treating peyronie's disease | |
| CN105560399A (en) | Compound ointment for treating corn and preparation method thereof | |
| CN104491196A (en) | Traditional Chinese medicine preparation for treating gastrorrhagia | |
| CN104645244A (en) | Traditional Chinese medicine composition for treating atherosclerosis | |
| CN104127782A (en) | Traditional Chinese medicine composition for treating benign paroxysmal positional vertigo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190517 |
|
| RJ01 | Rejection of invention patent application after publication |